www.bic.lv
Our company

BIC Securities is one of the leading independent groups of companies providing financial advisory services in the field of corporate finance in Central and Eastern Europe*.

The group companies operate and provide services to clients in Eastern Europe strictly within the framework of applicable European Union sanctions (2022–2026) and in full compliance with the relevant regulatory requirements.

Through our established market positioning and extensive network of contacts, we have all the necessary capabilities to effectively support our clients in capital transactions, primarily in mergers and acquisitions (M&A), including cross-border transactions.


Core markets:
  • Baltic States – Latvia, Lithuania and Estonia
  • Russia and EAEU countries
  • Ukraine
  • Nordic Countries

 

Other markets (also through partners' network):
  • UK, Germany, France
  • Czech Republic, Slovakia, Poland, Hungary, Slovenia, Romania, Bulgaria, Serbia
  • Selected other countries in Eastern Europe and the CIS
What's new
BIC Securities advised a European alcohol production and distribution group on an acquisition in the Baltics
05/10/2022
BIC Securities acted as an exclusive financial adviser to a European alcohol production and distribution group...
Read more

BIC Securities advised Klosterfrau Healthcare Group on acquisition of two products in Poland
28/06/2022
Klosterfrau Healthcare Group, a leading European pharmaceuticals provider has completed the transaction on acquisition of two branded products registered in Poland...
Read more

BIC Securities advised Digital Mind in acquisition of Alna Business group, leading Enterprise Resource Planning (ERP) solutions provider in Lithuania and Poland
20/05/2022
Digital Mind, business process digitalization specialist for large and mid-sized organizations in Baltic states is taking over Alna Business group, leading ERP solution provider in Lithuania and Poland...
Read more

BIC Securities advised Feron on acquisition of an API production business in Russia
01/04/2022
Feron, one of the leading Russian pharmaceutical companies, has acquired active pharmaceutical ingredients (API) production business...
Read more



Quick search



Copyright © 1999-2026 BIC Securities.
All rights reserved.